Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The tuberculosis vaccine challenge.

Michael J Brennan1

  • 1Laboratory of Mycobacterial Diseases and Cellular Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bldg 29 Rm 503 HFM-431, 29 Lincoln Drive, Bethesda, MD 20892, USA. brennan@cber.fda.gov

Tuberculosis (Edinburgh, Scotland)
|February 3, 2005
PubMed
Summary

Developing an effective tuberculosis (TB) vaccine is crucial for global control. New vaccines show promise, but challenges remain in using them for already infected populations in endemic areas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A nonlinear vibration isolator inspired by the arc-shaped multi-vertebra structure of a bird's neck.

Bioinspiration & biomimetics·2025
Same author

Layers of Genius: The Mohs Method and Its Maverick Inventor.

Cureus·2024
Same author

Use of PVDF Wire Sensors for Leakage Localization in a Fluid-Filled Pipe.

Sensors (Basel, Switzerland)·2020
Same author

The prescription opioid conundrum: 21st century solutions to a millennia-long problem.

Postgraduate medicine·2019
Same author

Adaptive Phase Transform Method for Pipeline Leakage Detection.

Sensors (Basel, Switzerland)·2019
Same author

Reduction of opioid use and improvement in chronic pain in opioid-experienced patients after topical analgesic treatment: an exploratory analysis.

Postgraduate medicine·2017

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Tuberculosis (TB) remains a global health challenge despite available antibiotic treatments.
  • Factors like re-infection, drug resistance, and HIV co-infection hinder TB control.
  • Existing pre-exposure vaccines may have limited impact in endemic regions where most of the population is already infected.

Purpose of the Study:

  • To evaluate the potential of new tuberculosis vaccine candidates.
  • To address the need for vaccines that can be administered to individuals already infected with Mycobacterium tuberculosis.
  • To identify challenges in the clinical evaluation and deployment of novel TB vaccines.

Main Methods:

  • Review of current tuberculosis vaccine development landscape.

Related Experiment Videos

  • Analysis of pre-clinical data from animal models.
  • Consideration of clinical trial data for safety and efficacy in human subjects.
  • Assessment of challenges in vaccinating populations with existing M. tuberculosis infection, BCG vaccination, or HIV co-infection.

    • Main Results:

    • Several new TB vaccine candidates are in development and clinical trials.
    • Some candidates demonstrate safety and efficacy in pre-clinical animal models.
    • Significant uncertainties exist regarding the safety and effectiveness of new TB vaccines in already infected or co-infected populations.

    Conclusions:

    • Vaccines delivered to individuals already infected with TB could significantly reduce disease burden.
    • Further research is needed to determine if new TB vaccines can be safely and effectively used in endemic populations.
    • Overcoming challenges in pre-clinical testing and clinical evaluation is essential for the successful uptake of new TB vaccines in high-risk areas.